- Home
- News
- Topics
- FDA Week
- Inside CMS
- Inside Drug Pricing
- Health Exchange Alert
- Inside TeleHealth
- About Us
Bill includes provisions for device user fees and establishing a new office of combination products. Click here for AdvaMed Statement Click here for Full Text Of Bill Click here for Summary Of Bill
/index.php?option=com_iwpfile&file=/dir_01/he2002_2551.pdf
/index.php?option=com_iwpfile&file=/dir_01/he2002_2550.pdf
ed
For Immediate Release
Wednesday, Oct. 2, 2002
Grassley, Baucus Bill Language Redirects Money to Uninsured Kids
WASHINGTON -- Medicare legislation from Sens. Max Baucus and Chuck Grassley would prohibit the Department of Health and Human Services from allowing states to divert federal funds that are dedicated to children's health to instead cover childless adults.
/index.php?option=com_iwpfile&file=/dir_01/he2002_2548.pdf
ss Bill
AARP, Rx Health Value and Coalition for a Competitive Pharmaceutical Market say the survey underscores the need for Congress to act now on drug patent reform legislation passed by the Senate.
ce
To: FDA-wide
Re: Establishment of Office of Pediatric Therapeutics
Today I am pleased to announce that on October 1, 2002 the Office of Pediatric Therapeutics (OPT) will be established within the Office of the Commissioner / Office of International Activities and Strategic Initiatives. This office will report to Murray M. Lumpkin, M.D. in his capacity as Senior Associate Commissioner.